| |
Association of British Clinicial Diabetologists
& Welsh Endocrine & Diabetes Society
Spring Meeting
"Now that's what I call Diabetes and Endocrinology" Hilton
Cardiff,
23rd & 24th April 2015
POSTERS FOR ONLINE VIEWING
1
Whole genome sequence based
analysis of thyroid function
Peter N. Taylor(1)*, Eleonora
Porcu(2,3,4)*, Shelby Chew(5)*, Purdey J. Campbell(5)*, Michela
Traglia(6),, Suzanne J. Brown(5), Benjamin H. Mullin(5),(7), Hashem
A. Shihab(8), Josine L. Min(8), Klaudia Walter(9), Yasin Memari(9),
Jie Huang(9), Michael R. Barnes(10), John P. Beilby(11),(12), Pimphen Charoen(13),(14), Petr Danecek(9), Frank Dudbridge(13), Vincenzo Forgetta(15),(16), Celia Greenwood(15),(16), Elin
Grundberg(17),(18), Andrew D. Johnson(19), Jennie Hui(11),(12), Ee M.
Lim(5),(11), Shane McCarthy(9), Dawn Muddyman(9), Vijay Panicker(5),
John R.B. Perry(20),(21), Jordana T. Bell(21), Wei Yuan(21),
Caroline Relton(8), Tom Gaunt(8), David Schlessinger(22), Goncalo
Abecasis(4), Francesco Cucca(2),(3), Gabriela L. Surdulescu(21),
Wolfram Woltersdorf(23), Eleftheria Zeggini(9), Houfeng
Zheng(15),(16), Daniela Toniolo(6),(24), Colin M. Dayan(1), Silvia
Naitza(2), John P. Walsh(5),(7), Tim D. Spector(21), George Davey
Smith(8), Richard Durbin(9), J. Brent Richards(15),(16),(21), Serena
Sanna(2), Nicole Soranzo(9), Nicholas J. Timpson(8)*, Scott G.
Wilson(5),(7),(21)* and the UK10K Consortium(25).
* Authors
contributed equally.
(1) Thyroid Research Group, Institute of Molecular &
Experimental Medicine, Cardiff University School of
Medicine, Cardiff University, Cardiff, United Kingdom:2)
Istituto
di Ricerca
Genetica e
Biomedica (IRGB),
Consiglio
Nazionale delle
Ricerche, c/o
Cittadella
Universitaria di
Monserrato,
Monserrato, Cagliari, Italy;
(3)
Dipartimento
di Scienze
Biomediche,
Università
di Sassari, Sassari, Italy;
(4)
Center for Statistical Genetics, Biostatistics Department,
University of Michigan, Ann
Arbor, MI, USA;
(5) Department of Endocrinology and Diabetes,
Sir Charles Gairdner Hospital,
Nedlands, Western Australia,
Australia;
(6) Division of Genetics and Cell Biology, San
Raffaele Research Institute,
Milano, Italy;
(7) School of Medicine and Pharmacology,
University of Western Australia, Crawley, Western Australia,
Australia;
(8) MRC Integrative Epidemiology Unit at the
University of Bristol, University of Bristol, Bristol,
United Kingdom;
(9) Wellcome
Trust Sanger Institute, Wellcome
Trust Genome Campus, Cambridge, United Kingdom;
(10) William
Harvey Research Institute, Barts
and The London School of Medicine and Dentistry, Queen Mary
University of London, London, United Kingdom;
(11)
Pathwest Laboratory Medicine WA,
Nedlands, Western Australia, Australia;
(12) School of Pathology and Laboratory Medicine, University
of Western Australia, Crawley, Western Australia, Australia;
(13) Faculty of Epidemiology and Population Health, London
School of Hygiene and Tropical Medicine, London, United
Kingdom;
(14) Department of Tropical Hygiene, Faculty of
Tropical Medicine, Mahidol
University, Bangkok, Thailand;
(15) Department of Medicine,
Jewish General Hospital, McGill University, Montréal Québec,
Canada;
16) Departments of Human Genetics, Epidemiology, and
Biostatistics, Jewish General Hospital, Lady Davis
Institute, McGill University, Montréal Québec, Canada;
17)
Department of Human Genetics, McGill University, Montreal,
QC H3A1A5, Canada;
(18) McGill University and Genome Quebec
Innovation Centre, Montreal, QC H3A1A5, Canada;
(19)
Cardiovascular Epidemiology and Human Genomics Branch,
National Heart, Lung and Blood Institute, Bethesda, MD, USA;
(20) MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine,Box 285,
Institute of Metabolic Science, Cambridge Biomedical Campus,
Cambridge, United Kingdom;
(21) Department of Twin Research
and Genetic Epidemiology, King’s College London, London,
United Kingdom;
22) Laboratory of Genetics, NIA, Baltimore,
MD 21224, USA;
(23) Facharzt
für
Laboratoriumsmedizin,
Geschäftsführer amedes
Ost, Halle/Leipzig GmbH,
Leipziger
Chaussee 191f, 06112 Halle (Saale), Germany;
(24) Institute
of Molecular Genetics–CNR, Pavia, Italy
Poster not provided for on line viewing
2 Reliability
of a post partum fasting glucose in the management of women with
gestational diabetes
Peter
N Taylor(1),(2), Gautam Das(1), Arshiya Tabsum(1), Elizabeth Bradley(1), David
Burberry(1)Dawn Lee(1) Piero Baglioni(1), Anthony Robinson(3), Onyebuchi E
Okosieme(1),(2)
(1)Endocrinology and Diabetes Department, Prince Charles Hospital,
Cwm Taf University Health Board, Merthyr Tydfil;
(2) Institute of
Molecular and Experimental Medicine, Cardiff University School of
Medicine, Cardiff;
(3) Department of Diabetes and Endocrinology,
Royal United Hospital, Bath.
Click here to view poster
3
Dapagliflozin is more effective in the most poorly controlled
diabetic
T Min(1), (2), A Dixon(2), A Mallipedhi(1), P Varnavas(2), C McIver(1),
D Price(1), J Stephens(1), J Harvey(2)
(1)Department of Diabetes and
Endocrinology, Morriston Hospital, Swansea, SA6 6NL;
(2)Department of
Diabetes and Endocrinology, Wrexham Maelor Hospital,
Wrexham, LL13 7TD
Click here to view poster
4 Correlations
between cardiovascular risk factors and TBPI v Doppler in patients
with type2 diabetes
L Lomova-Williams(1), A Mallipedhi(1),(2),
D E Price(1), R Thomas(1), C Ferguson(1),(2), S Bain(1),(2),
J W Stephens(1),(2)
(1)Department of Diabetes &
Endocrinology, Morriston Hospital, ABM University Health,
Swansea SA6 6NL;
(2) Diabetes Research
Group, Institute of Life Sciences, Swansea University SA2
8PP
Click here
to view poster
5
Pancreatic Enzyme supplmentation in diabetes
Witczak JK(1), Evans PJ(1)
(1) Royal Gwent Hospital, Aneurin Bevan Health Board
Click here
to view poster
6 Local
pregnancy and foetal outcomes in GDM in Gloucestershire
Emily Renninson(1), Sarah
Murray(1), Tripti Mahajan(1)
(1)Diabetes and Endocrinology Department, Gloucester Royal
Hospital, Great Western Road, Gloucester GL1 3NN
Poster not provided for on line viewing
7
Cardiovascular risk prediction in
subjects at high risk of type 2 diabetes mellitus: Do different risk
predictors give the same results
L Lomova-Williams(1), A Mallipedhi(1),(2), R Tristham(3),
G Lake(3), J W Stephens(1),(2)
(1) Department of Diabetes & Endocrinology, Morriston
Hospital, ABM University Health, Swansea SA6 6NL;
(2) Diabetes Research Group, Institute of Life Sciences,
Swansea University SA2 8PP;
(3) Clydach Primary Care Centre, Clydach, Swansea, SA6
5LN.
Click here to view poster
8
Clinical testing of an internet web
based tool for risk assessment and management of IP with diabetes
M Choudhary(1), K Boregowda(1), H Bolusani(1) & A
Roberts(1)
(1)Department of Diabetes and Endocrinology, University
Hospital of Wales, Cardiff
Click here to view poster
9 All
Wales audit and real world outcomes on the use of Dapagliflozin in
the management of T2DM
V S Eligar(1), M Nassrullah(1),S Zouras(2), S Rice(2), A
Kalhan(1), A Roberts(1) and H Bolusani(1)
(1)University Hospital of Wales, Cardiff, 2Prince Philip
Hospital
Click here to view poster
10 Type
2 diabetes, basal Insulin and the experience of hypos: Insights from
the patient perspective
Jen Nash(1), Amar Ali(2), Grace Vanterpool(3), Philippa
Hammerton(4), Richard Hudson(5)
(1) Chartered Psychologist with the British Psychological
Society, Director of ‘Positive diabetes’;
(2) GPWSI Diabetes, Oakenhurst Surgery, Blackburn;
(3)Diabetes Nurse Consultant, London Northwest
Healthcare NHS Trust;
(4)RedLeaf Research Limited, Guildford; (5)Sanofi,
Guildford, United Kingdom
Click here to view poster
11 Awareness
of driving regulations and safe driving requirements for people with
Insulin treated diabetes: Health Care Professional Perspectives
Thinzar Min(1)
(1) Diabetes Department, Morriston Hospital, Swansea
Click here to view poster
12 Experience
with Dapagliflozin at the Royal Cornwall Hospital
Michael Gilroy(1)
(1)Endocrinology and Diabetes, Royal Cornwall Hospital
Treliske, Truro
Click here to view poster
13 HES
data, patient experience and local statistics - can peer reviews of
diabetes foot care services improve outcomes
Richard Paisey(1)
(1) Horizon Centre, Torbay Hospital, Torquay, TQ2 7AA
Click here to view poster
14 Audit
of the outcomes of adding an SGLT2 inhibitor to Insulin in sub
optimally controlled T2DM patients
L S Cozma(1), S Benjamin(1), S Roy-Chawdhury(1)
(1)Diabetes Centre, Princess of Wales Hospital, ABMU Health
Board, Bridgend, South Wales
Click here to view poster
15 Weight
change and sustained improvement in glyceamic control over 5 years
in patients with T2DM on U500 Insulin
Umesh Dashora(1), Erwin Castro(1)
(1) Conquest Hospital, Hastings
Poster not provided for on line viewing
16 Injection
site reaction secondary to GLP1 therapy
P Srivatsava(1), K Boregowda(1), M Choudhury(1), Aled
Roberts(1), Hemanth Bolusani(1)
(1)Department of Diabetes and Endocrinology, University
Hospital of Wales, Cardiff
Click here
to view poster
17 Hyperglycemia
post pancreas transplantation in a case of Alstrom's syndrome with
diabetes
M Choudhary(1), K Boregowda(1), A Roberts(1), H Bolusani(1),
C Dayan(1)
(1) Department of Diabetes and Endocrinology, University
Hospital of Wales, Cardiff
Click here
to view poster
18 Cushings
Syndrome in assocaition with Osteoporosis
Pranav Kumar(1), Maneesh Udiawar(1),
Santosh Shankarnarayan(1), David Price(1)
(1) Morriston Hospital , Swansea SA6 6NL
Click here
to view poster
19 The
weekly injection: A practical soultion to an old crisis
Peter Taylor(1),(2), Arshiya Tabasum(1), John Geen(1),
Gina Sanki(1), Brian Tennant(1), Andrew Aldridge(1),
Onyebuchi Okosieme(1),(2) and Gautam Das(1)
(1) Endocrinology and Diabetes Department, Prince Charles
Hospital, Cwm Taf University Health Board, Merthyr Tydfil;
(2)Institute of Molecular and Experimental Medicine,
Cardiff University School of Medicine, Cardiff.
Click here
to view poster
20 An
unexplained case of chronic back pain: A large Pheochromocytoma in a
55 year old women
Stamatios Zouras(1), Sam Rice(1),
Jayne Evans(1), Tom N W Evans(1)
(1)Prince Philip Hospital, Mawr Dafen Road, Llanelli,
Carmarthenshire
Click here
to view poster
|
|